XML 12 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - shares
3 Months Ended
Mar. 31, 2023
May 03, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2023  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 001-39318  
Entity Registrant Name Lantern Pharma Inc.  
Entity Central Index Key 0001763950  
Entity Tax Identification Number 46-3973463  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 1920 McKinney Avenue  
Entity Address, Address Line Two 7th Floor  
Entity Address, City or Town Dallas  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 75201  
City Area Code (972)  
Local Phone Number 277-1136  
Title of 12(b) Security Common Stock, $0.0001 par value  
Trading Symbol LTRN  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period true  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   10,857,040